Status:
COMPLETED
Effectiveness of Polymyxin B Sulphate + Prednisolone + Benzocaine + Clioquinol in Acute and Sub-acute Dermatitis Eczematous
Lead Sponsor:
EMS
Conditions:
Eczema
Eligibility:
All Genders
18-40 years
Phase:
PHASE3
Brief Summary
Dermatitis eczematous is a recurrent pruritic skin disorder which has a significant morbidity and impaired quality of life due specially pruritus and physical visible skin lesions. The purpose of this...
Detailed Description
Study design: * Experiment duration: 22 days * 2 visits (days 0,7,15 and 22) * Reducing eczema area and severity index evaluation * Adverse events evaluation * Double blinded, non-inferiority, prospe...
Eligibility Criteria
Inclusion
- Patients must be able to understand the study procedures agree to participate and give written consent.
- Patients with acute or subacute dermatitis with a minimum of 3 symptoms.
Exclusion
- Pregnancy or risk of pregnancy.
- Lactation
- Use of anti-inflammatory or immunosuppressive drugs (last 30 days prior to the study).
- Sunlight over exposure in the last 15 days.
- Any pathology or past medical condition that can interfere with this protocol.
Key Trial Info
Start Date :
May 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2012
Estimated Enrollment :
76 Patients enrolled
Trial Details
Trial ID
NCT01429701
Start Date
May 1 2012
End Date
August 1 2012
Last Update
February 24 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.